Pandemic preparedness cannot rely on vaccine development alone
Vaccine experts drew attention to disruption factors around vaccine development and key action plans for future pandemic preparedness planning.
Feature
Event summary: Clinician-scientist-engineer challenges workshop in infection
Leading infection experts came together to explore clinical challenges in infection and how Imperial’s interdisciplinary expertise can solve them.
Future perspectives on mRNA technology in the UK
mRNA technology revolutionised our traditional approach to vaccine technology in the wake of COVID-19. But what next for the platform?
Vaccine Student Research Network Conference 2024
The Vaccine Student Research Network has recently hosted its inaugural conference at South Kensington campus.
Cellular factories - Engineering biology symposium and IMSE Annual Lecture
IMSE welcomed researchers in the field of Engineering Biology for an engaging symposium which concluded with Prof. Kristala Prather keynote lecture
Sir Michael Uren prize awarded for excellence in epidemiological research
Bethan Cracknell-Daniels has been awarded the Sir Michael Uren Prize for her pioneering research in epidemiology, focusing on dengue vaccine efficacy.
Imperial’s CBRB appoints new co-directors
Professor Mariagrazia Pizza and Professor Shiranee Sriskandan will lead the Centre for Bacterial Resistance Biology (CBRB).
HIC-Vac: Improving vaccine development through human challenge studies
Professor Peter Openshaw explains how HIC-Vac is developing human challenge studies to improve vaccines against major infections.
Imperial launches new online courses on virology and vaccinology
A new online Coursera series will explore how viruses infect us, how vaccines protect us and the latest cutting-edge infectious disease research.
Global human challenge consortium to push for next generation of vaccines
An international group of researchers specialising in human challenge studies is embarking on a project to develop advanced virus-blocking vaccines.
